Evaluation of the sensitivities of six triple-negative breast cancer (TNBC) cell lines to 23 different PI3K/AKT/mTOR inhibitors or to a MEK inhibitor (trametinib). Dataset 1 of 2: GR values. - Dataset (ID:20364)

Filter results: >>>>
Cell line Drug name Experimental replicate Timepoint Drug concentration Live cell count Average live cell count, DMSO control Average live cell count (time = 0) Log10(drug concentration) GR value Relative cell count (treatment versus DMSO) Cell doublings (DMSO control) Experiment name
HCC1806 TGX221 3 72
0.0032
11187.8 11158.5 1273.3
-2.49
1.000 1.000 3.132
HCC1806 TGX221 0 3 72
HCC1806 TGX221 3 72
0.01
11230.5 11158.5 1273.3
-2.0
1.000 1.010 3.132
HCC1806 TGX221 0 3 72
HCC1806 TGX221 3 72
0.032
11433.8 11158.5 1273.3
-1.49
1.020 1.020 3.132
HCC1806 TGX221 0 3 72
HCC1806 TGX221 3 72
0.1
11446.3 11158.5 1273.3
-1.0
1.020 1.030 3.132
HCC1806 TGX221 0 3 72
HCC1806 TGX221 3 72
0.32
11531.3 11158.5 1273.3
-0.495
1.020 1.030 3.132
HCC1806 TGX221 0 3 72
HCC1806 TGX221 3 72
1.0
11205.8 11158.5 1273.3
0.0
1.000 1.000 3.132
HCC1806 TGX221 0 3 72
HCC1806 TGX221 3 72
3.2
11540.3 11158.5 1273.3
0.505
1.020 1.030 3.132
HCC1806 TGX221 0 3 72
HCC1806 Torin1 3 72
0.001
11438.8 11764.8 1273.3
-3.0
0.983 0.972 3.208
HCC1806 Torin1 0 3 72
HCC1806 Torin1 3 72
0.0032
11138.3 11764.8 1273.3
-2.49
0.966 0.947 3.208
HCC1806 Torin1 0 3 72
HCC1806 Torin1 3 72
0.01
9981.5 11764.8 1273.3
-2.0
0.900 0.848 3.208
HCC1806 Torin1 0 3 72
HCC1806 Torin1 3 72
0.032
8862.3 11764.8 1273.3
-1.49
0.831 0.753 3.208
HCC1806 Torin1 0 3 72
HCC1806 Torin1 3 72
0.1
6527.8 11764.8 1273.3
-1.0
0.664 0.555 3.208
HCC1806 Torin1 0 3 72
HCC1806 Torin1 3 72
0.32
5149.3 11764.8 1273.3
-0.495
0.546 0.438 3.208
HCC1806 Torin1 0 3 72
HCC1806 Torin1 3 72
1.0
4599.5 11764.8 1273.3
0.0
0.492 0.391 3.208
HCC1806 Torin1 0 3 72
HCC1806 Torin1 3 72
3.2
3197.0 11764.8 1273.3
0.505
0.332 0.272 3.208
HCC1806 Torin1 0 3 72
HCC1806 Torin2 3 72
0.001
11442.3 11795.0 1273.3
-3.0
0.981 0.970 3.212
HCC1806 Torin2 0 3 72
HCC1806 Torin2 3 72
0.0032
11163.3 11795.0 1273.3
-2.49
0.966 0.946 3.212
HCC1806 Torin2 0 3 72
HCC1806 Torin2 3 72
0.01
9689.3 11795.0 1273.3
-2.0
0.881 0.821 3.212
HCC1806 Torin2 0 3 72
HCC1806 Torin2 3 72
0.032
7731.3 11795.0 1273.3
-1.49
0.754 0.655 3.212
HCC1806 Torin2 0 3 72
HCC1806 Torin2 3 72
0.1
3607.0 11795.0 1273.3
-1.0
0.383 0.306 3.212
HCC1806 Torin2 0 3 72
HCC1806 Torin2 3 72
0.32
1227.5 11795.0 1273.3
-0.495
-0.011 0.104 3.212
HCC1806 Torin2 0 3 72
HCC1806 Torin2 3 72
1.0
999.5 11795.0 1273.3
0.0
-0.073 0.085 3.212
HCC1806 Torin2 0 3 72
HCC1806 Torin2 3 72
3.2
931.5 11795.0 1273.3
0.505
-0.093 0.079 3.212
HCC1806 Torin2 0 3 72
HCC1806 Trametinib 3 72
0.001
11633.3 11736.5 1273.3
-3.0
0.994 0.991 3.204
HCC1806 Trametinib 0 3 72
HCC1806 Trametinib 3 72
0.0032
10675.8 11736.5 1273.3
-2.49
0.942 0.910 3.204
HCC1806 Trametinib 0 3 72